引用本文:
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 943次   下载 1519 本文二维码信息
码上扫一扫!
分享到: 微信 更多
光照对阿尔茨海默病的影响研究进展
严永红1, 骆玉洁2
1.重庆大学建筑城规学院, 山地城镇建设 与新技术教育部重点实验室,教授,博士 生导师,65120701@126.com;2.重庆大学建筑城规学院, 硕士研究生
摘要:
研究表明褪黑素的含量下降可能与 阿尔茨海默病(AD)的发病以及其患者的睡 眠障碍有关。大量研究显示光照强度和光谱 能量分布等均可影响人体褪黑素的分泌,适 宜的光照可改善AD患者的睡眠障碍。此外, AD患者这一特殊群体对建筑光环境的要求 也有特殊性:如日光的最大化利用;对于人工 光而言,则要求使用较高的照度水平、尽可能 消除眩光、避免光照水平的突然变化及不同 亮度区域间提供适当的过渡照明等。合理的 建筑光环境设计可改善AD患者的生活质量, 减少其异常行为,改善其睡眠障碍。研究光 照对阿尔茨海默病的影响将对阿尔茨海默病 的预防和治疗,甚至对AD患者的日常管理起 到积极的作用。论文对AD患者褪黑素水平与 睡眠障碍的关系、人工光照强度与光谱分布 对患者褪黑素分泌水平的影响、人工光照对 AD病症的辅助治疗方案等相关研究的进展 进行了介绍。
关键词:  阿尔茨海默病(A D)  褪黑素 (MT)  睡眠障碍  光照强度  光谱  建筑光 环境
DOI:10.13791/j.cnki.hsfwest.20150601
分类号:
基金项目:国家自然科学基金面上项目(51178483; 51378518)
Research Progress of Light Effects on Alzheimer Disease
YAN Yonghong,LUO Yujie
Abstract:
Previous studies have suggested the melatonin levels may be associated with the incidence of Alzheimer Disease (AD) and the sleep disorder of the patients. A large number of studies have indicated that illumination intensity and spectral energy distribution can affect the secretion of melatonin in human body, and appropriate light can improve the sleep quality of the AD patients. Besides, AD patients also have special requirements for building the light environment. For example, the daylight should be used as much as possible; for the artificial light, there should be a higher level of illumination and the glare and sudden changes of illumination levels should be avoided. So the appropriate transition lighting between the areas of different brightness should be provided. Reasonable design of building light environment can improve the quality of AD patients’ lives, reduce their abnormal behavior and improve their sleep quality. Therefore, studies of the light effects on AD will play a positive role on the prevention and treatment of AD. And this paper will introduce the research progress on the relationship between melatonin levels and sleep disturbance of AD patients, the effects of artificial light intensity and spectral distribution on the secretion of melatonin of patients, and the adjuvant therapy to AD by using the artificial light.
Key words:  Alzheimer Disease  Melatonin  Sleep Disorder  Illumination Intensity  Spectrum  Building Light Environment